Glen C. MacDonald
Net Worth
Last updated:
What is Glen C. MacDonald net worth?
The estimated net worth of Dr. Glen C. MacDonald is at least $1,154,628 as of 2 Mar 2023. He has earned $115,228 from insider trading and has received compensation worth at least $1,039,400 in Sesen Bio, Inc..
What is the salary of Glen C. MacDonald?
Dr. Glen C. MacDonald salary is $519,700 per year as Chief Technology Officer in Sesen Bio, Inc..
How old is Glen C. MacDonald?
Dr. Glen C. MacDonald is 74 years old, born in 1951.
What stocks does Glen C. MacDonald currently own?
As insider, Dr. Glen C. MacDonald owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Sesen Bio, Inc. (SESN) | Chief Technology Officer | 206,751 | $0 | $0 |
What does Sesen Bio, Inc. do?
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Glen C. MacDonald insider trading
Sesen Bio, Inc.
Dr. Glen C. MacDonald has made 4 insider trades in 2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 183,317 units of SESN stock on 2 Mar 2023. As of 2 Mar 2023 he still owns at least 206,751 units of SESN stock.
Sesen Bio key executives
Sesen Bio, Inc. executives and other stock owners filed with the SEC:
- Dr. Glen C. MacDonald (74) Chief Technology Officer
- Dr. Thomas R. Cannell (63) Pres, Chief Executive Officer & Director
- Ms. Monica Forbes (49) Chief Financial Officer & Treasurer